Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1177/17474930241264685 | ||||
| Año | 2024 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Background: Stroke is a leading global cause of death and disability. Daily tea/coffee intake is consumed by > 50% of populations and may represent an important population-level exposure. Therefore, it is first essential that we better understand the associations between the tea/coffee intake and stroke. Aims: This research aims to generate hypotheses about the global associations between tea and coffee intake and stroke. These insights will identify interventions for stroke prevention that can be further explored using alternative study designs. Methods: INTERSTROKE is a large international matched case-control study of first stroke from 32 countries. Participants were asked "how many cups do you drink each day?" of coffee, green tea, black tea, and other tea. Multivariable conditional logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between intake and stroke. Results: We included 13,462 cases and 13,488 controls from INTERSTROKE; mean age was 61.7 (13.4) years and 59.6% (n = 16,010) were male. Overall, 19.4% (n = 5239) did not consume tea/coffee, 47.0% (n = 12,666) consumed tea only, 14.9% (n = 4024) consumed coffee alone, and 18.6% (n = 5021) consumed both, with significant regional variations. After multivariable adjustment, there was no association between low/moderate coffee intake and stroke, but high consumption (> 4/day) was associated with higher odds of all stroke (OR = 1.37 (95% CI = 1.06-1.77)) or ischemic stroke (OR = 1.32 (95% CI = 1.00-1.74)). Tea consumption was associated with lower odds of all (OR = 0.81 (95% CI = 0.69-0.94) for highest intake) or ischemic stroke (OR = 0.81 (95% CI = 0.68-0.98) for highest intake). Conclusions: High coffee consumption was associated with higher odds of all or ischemic stroke; low-moderate coffee had no association with stroke. In contrast, tea consumption was associated with lower odds of stroke. These associations suggest that individuals consider avoiding high coffee consumption (>= five cups/day) to impact future stroke risk. Data Access Statement: The design and rationale of INTERSTROKE was published previously. Individual participant data, or other documents are not available.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Smyth, Andrew | Hombre |
MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá Univ Galway - Irlanda Hamilton Health Sciences - Canadá University of Galway - Irlanda |
| 2 | Hankey, Graeme J. | Hombre |
Univ Western Australia - Australia
UWA Medical School - Australia |
| 3 | Langhorne, Peter | Hombre |
Univ Glasgow - Reino Unido
University of Glasgow - Reino Unido |
| 4 | Reddin, Catriona | - |
Univ Galway - Irlanda
University of Galway - Irlanda |
| 5 | Ryglewicz, Danuta | Mujer |
Mil Inst Aviat Med - Polonia
Military Institute of Aviation Medicine - Polonia |
| 6 | Rosengren, Annika | Mujer |
Univ Gothenburg - Suecia
Sahlgrenska Universitetssjukhuset - Suecia |
| 7 | Xavier, Denis | Hombre |
St Johns Med Coll & Res Inst - India
St. John's National Academy Of Health Sciences India - India |
| 8 | Canavan, M. | Mujer |
Univ Galway - Irlanda
University of Galway - Irlanda |
| 9 | Oveisgharan, Shahram | Hombre |
Rush Univ - Estados Unidos
Rush University Medical Center - Estados Unidos |
| 10 | Wang, Xingyu | - |
Beijing Hypertens League Inst - China
Beijing Hypertension League Institute - China |
| 11 | Jaramillo, Patricio Lopez | - |
Univ Santander - Colombia
Univ UTI - Ecuador Universidad de Santander - Colombia Universidad UTI - Ecuador |
| 12 | Damasceno, Albertino | Hombre |
Eduardo Mondlane Univ - Mozambique
Universidade Eduardo Mondlane - Mozambique |
| 13 | Czlonkowska, Anna | Mujer |
Inst Psychiat & Neurol - Polonia
Institute of Psychiatry and Neurology, Warszawa - Polonia |
| 14 | Iversen, Helle K. | Mujer |
Univ Copenhagen - Dinamarca
Rigshospitalet - Dinamarca |
| 15 | LANAS-ZANETTI, FERNANDO TOMAS | Hombre |
Universidad de La Frontera - Chile
|
| 16 | Yusuf, Salim | Hombre |
MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá Hamilton Health Sciences - Canadá |
| 17 | O’Donnell, Martin J. | Hombre |
MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá Univ Galway - Irlanda Hamilton Health Sciences - Canadá University of Galway - Irlanda |
| Fuente |
|---|
| National Institutes of Health |
| European Commission |
| European Union |
| DFG |
| BMBF |
| Swedish Research Council |
| Stroke Association |
| Bundesministerium für Bildung und Forschung |
| Boehringer Ingelheim (Canada) |
| Swedish Heart and Lung Foundation |
| AstraZeneca |
| Boehringer Ingelheim |
| German Ministry of Education and Research (BMBF) |
| MSD |
| German Research Council |
| German Research Council (DFG) |
| Chest, Heart and Stroke Scotland |
| Pfizer (Canada) |
| UK Stroke Research Network |
| Canadian Stroke Network |
| Bertelsmann Foundation |
| Heinz-Nixdorf Foundation |
| Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland |
| Chest Heart and Stroke Scotland |
| Hjärt-Lungfonden |
| Canadian Institutes of Health Research, Heart and Stroke Foundation (Canada) |
| Health & Medical Care Committee of the Vaestra Goetaland Regional Executive Board (Sweden) |
| Stroke Association, UK Stroke Research Network |
| Canadian Institutes of Health Research, Heart and Stroke Foundation |
| Agradecimiento |
|---|
| The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The INTERSTROKE study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation (Canada), Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, Health & Medical Care Committee of the Vaestra Goetaland Regional Executive Board (Sweden), unrestricted grants (AstraZeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MSD), Chest, Heart and Stroke Scotland, and the Stroke Association, UK Stroke Research Network, German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, National Institutes of Health, Bertelsmann Foundation, and Heinz-Nixdorf Foundation. |
| The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The INTERSTROKE study was funded by the Canadian Institutes of Health Research, Heart and Stroke Foundation (Canada), Canadian Stroke Network, Swedish Research Council, Swedish Heart and Lung Foundation, Health & Medical Care Committee of the V\u00E4stra G\u00F6taland Regional Executive Board (Sweden), unrestricted grants (AstraZeneca, Boehringer Ingelheim (Canada), Pfizer (Canada), MSD), Chest, Heart and Stroke Scotland, and the Stroke Association, UK Stroke Research Network, German Research Council (DFG), German Ministry of Education and Research (BMBF), European Union, National Institutes of Health, Bertelsmann Foundation, and Heinz-Nixdorf Foundation. |